If you've been told your labs are "normal" but you still feel profoundly unwell — exhausted, anxious, foggy, in pain — and a hundred specialists have come up empty, this article is for you. May is Lyme Disease Awareness Month, and this is Part 1 of a two-part series on what chronic Lyme really is, why it's so consistently missed, and what it actually takes to heal.
Watch the full Part 1 presentation — or read the deep-dive article below.
May Is Lyme Disease Awareness Month
A growing recognition of an often-dismissed disease.
Lyme disease was once dismissed by mainstream medicine as rare and self-limiting. Today it is the most common vector-borne illness in the United States — and the chronic form is finally beginning to gain recognition.
Yet on a good day, mainstream medicine still recognizes only acute Lyme — not the post-treatment, persistent form so many of you are living with. The result is patients dismissed, undiagnosed for years, and told it's "all in your head."
📺 Recommended viewing: Under Our Skin (2008) — a powerful documentary capturing patients' experiences of dismissal and the search for chronic Lyme treatment.
IMPORTANT DISCLAIMERS
- Educational purpose only. This article is for education and does not constitute medical advice, diagnosis, or treatment. It reflects the clinical opinion and experience of the author.
- FDA status. Several therapies discussed (EBOO ozone, SOT/RGCC, Field Control Therapy, Autonomic Response Testing, low-dose immunotherapy, and others mentioned in Part 2) are not FDA-approved for Lyme or any other condition. They are used in our clinic in a supportive, integrative role.
- Off-label use. Any prescription medications mentioned (maraviroc, atorvastatin, dapsone, others) when used for chronic Lyme or long COVID represent off-label use, only undertaken under qualified medical supervision and informed consent.
- Individual results vary. Patient outcomes referenced are individual experiences, not guarantees. Chronic Lyme is complex; treatment must be individualized.
- Bioenergetic methods. Bioenergetic and energetic testing techniques are not validated by conventional medical standards and should be considered complementary to — not a replacement for — appropriate medical evaluation.
The Scope of the Problem
Lyme is no longer rare — it is widespread and growing.
Lyme Cases / Year
(CDC current estimates)
After Standard Antibiotic
Treatment
Delay for Chronic Lyme
From Symptom Onset
Ancient Bugs, Modern Problem
Why are these old pathogens making us sick now?
Here is a clue most people don't know: Lyme spirochetes have been recovered from a 5,000-year-old mummy. That mummy did not die from Lyme — he appeared otherwise healthy, and his death was caused by blunt head trauma.
The takeaway is profound: Borrelia and its co-travelers have lived alongside humans as part of our natural microbiome for millennia. So what changed?
Our terrain changed.
- 80,000+ industrial chemicals in widespread circulation
- Unrelenting chronic stress and burnout
- Nutritional deficiencies and ultra-processed diets
- Widespread circadian rhythm disruption
- Mold and water-damaged building exposure
- Post-COVID immune dysregulation
Lyme Is Not Just Transmitted by Ticks
Vectors of Borrelia transmission go beyond what most doctors know.
| Vector | What we know |
|---|---|
| Ticks | The primary vector — but far from the only one. |
| Mosquitoes | Borrelia DNA has been detected in mosquito populations. |
| Spiders | Suspected vectors in published case reports. |
| Sand fleas | Bites from beach areas have been implicated. |
| Pet fleas | Pet-to-human transmission appears possible. |
| Sexual transmission | Documented in the research literature. |
Many patients have no recollection of a tick bite. That alone does not rule out Lyme.
Could THIS Be Lyme?
Symptoms that should make you pause and ask the question.
- Joint pain & swellingOften shifting, often the knees
- Chronic fatigueWorse than expected for life circumstances
- Anxiety, depression, panicNew onset or treatment-resistant
- Brain fog & memory issuesWord-finding difficulties common
- InsomniaTrouble falling or staying asleep
- Neuropathy & tinglingEspecially feet, hands, scalp
- Heart palpitations / POTSAutonomic dysregulation
- Floaters, blurred visionEye involvement is common
Lyme often hides in joints and the spine — we frequently detect it there using Autonomic Response Testing (ART).
The Three Bad Actors
Lyme is rarely a single-pathogen disease.
Also frequently present: Rickettsia, Anaplasma, Mycoplasma, retroviruses, parasites, and reactivated EBV.
Lyme Can Trigger Autoimmune Disease
When the immune system attacks the wrong target.
How it happens
Borrelia hides inside cells and within biofilms. Your immune system senses something is wrong, but cannot identify the invader precisely. So it attacks the entire infected cell — destroying healthy tissue along with the pathogen. That collateral damage is what we recognize as autoimmune attack.
Conditions potentially triggered by Lyme
- Rheumatoid arthritis
- Lupus (SLE)
- Hashimoto's thyroiditis
- Multiple sclerosis
- Psoriatic arthritis
- POTS / dysautonomia
If you've been told you have an autoimmune disease but aren't getting better — investigate Lyme.
The "One Drop" Diagnostic
When the body responds to a microscopic dose, it tells us what we need to know.
Picture this: a patient comes in with unexplained joint pain, anxiety, or insomnia. We give them a single drop of homeopathic Lyme remedy, a low-dose immunotherapy (LDI) preparation, or a potent herbal antimicrobial like Byron White A-L Complex — and they have a clear Herxheimer/detox reaction, or, conversely, dramatic symptom improvement.
That response is itself diagnostic. The body recognizes the signature of the pathogen and modulates its own response — no standard lab test required. This is the principle behind LDI and provocative herbal antimicrobial trials, which we'll cover in detail in Part 2.
The Alzheimer's Connection
Spirochetes have been found in the brains of Alzheimer's patients.
Researchers — most notably the late Dr. Alan MacDonald — have documented Lyme spirochetes in the brains of patients with Alzheimer's disease. The implications are difficult to overstate.
- Some cases of cognitive decline may be infectious in origin.
- Chronic neuroinflammation from spirochetes may drive plaque formation.
- Treating the underlying infection may slow or modify progression in select patients.
- This is a strong reason to take chronic Lyme seriously — even silent infections.
Research is ongoing — causation versus correlation is still being studied.
Lyme and Neurological Disease
When "mystery" neurological diagnoses may have an infectious driver.
| Diagnosis | What the literature suggests |
|---|---|
| Parkinson's | Multiple case reports and an infectious-burden case-control study link Borrelia to substantia nigra inflammation and Parkinsonism. |
| Multiple Sclerosis | Borrelia appears in MS etiology reviews; demyelination patterns can mimic — or be triggered by — chronic Lyme. |
| ALS | Anecdotal case reports describe Lyme/Bartonella in ALS-pattern presentations. Population-level evidence is lacking. (See Healing ALS by Dr. Lee Cowden — 47-step protocol.) |
The evidence here is largely case-report and correlational; geographic-correlation studies have not shown a population-level link. These connections expand the differential when patients aren't getting better.
Why Standard Testing Fails
The tests your doctor likely ordered were not designed for chronic Lyme.
The limits of standard testing
- ELISA: poor sensitivity, frequent false negatives.
- Western blot: requires a robust immune response — chronic Lyme often suppresses one.
- IgG only reflects past exposure, not active infection.
- PCR: Lyme rarely lives in blood — false negatives are common.
- Misses biofilm-protected and tissue-bound forms entirely.
- CD57+ NK cell count is an indirect, non-specific immune marker — supportive only.
A telling structural difference: IGeneX ImmunoBlot uses 26 IgM + 31 IgG antigen-band slots (57 total). The CDC standard uses 3 IgM + 10 IgG (13 total). That's 44 additional class-specific band slots the CDC standard simply doesn't look at.
Advanced testing options we use
| Test | What it offers |
|---|---|
| T Lab | PCR + RNA FISH probes for Borrelia, Babesia, Bartonella (~$2,800). |
| Phelix Phage Borrelia (RedLabs) | High specificity. |
| Elispot T-cell activation (InfectoLab) | Detects active immune response. |
| DNA Connections | Provoked urine PCR. |
| IGeneX ImmunoBlot + FISH | Bartonella and Babesia FISH probes. |
| Vibrant Tickborne 2.0 | Microarray + PCR multi-pathogen panel — 16 Lyme-group strains (vs. 9 for IGeneX), 2 extra Bartonella antigens, plus a viral/opportunistic panel: Powassan, TBE, West Nile, Mycoplasma, Chlamydophila, CMV, EBV, HHV-6/7, HSV-1/2, Parvovirus B19, Toxoplasma. |
Even the best tests have blind spots — labs alone cannot guide recovery.
Lyme Is Profoundly Evasive
Three reasons normal blood tests routinely miss it.
This is why a normal blood test does not mean you don't have Lyme.
The Symptom Overlap Problem
Lyme, mold, EBV, and post-COVID share a remarkably similar symptom profile.
Without targeted testing, these four conditions look almost identical to most clinicians: fatigue, brain fog, joint pain, anxiety, sleep disruption, autonomic instability. Sorting them out requires both clinical pattern recognition and the right diagnostic tools.
Differentiating with Cytokine Patterns
Dr. Bruce Patterson's Long Hauler Index can help identify the dominant driver.
How it works
The test measures cytokine ratios — particularly IL-2 / CCL4 and IFN-γ / CCL4 — and generates a cytokine "fingerprint" that helps differentiate Long COVID, chronic Lyme, ME/CFS, and overlapping presentations. Available through Radiance Diagnostics.
Example patient — dual long-COVID + Lyme signature
| IL-2 / CCL4 ratio | 8.83 (normal ≤ 3.5) |
| IFN-γ / CCL4 ratio | 7.05 (normal ≤ 3.5) |
| Long Hauler Index | 15.87 (elevated) |
This pattern indicates ongoing T-cell activation and vascular inflammation — making this patient a candidate for precision anti-inflammatory therapy (covered in Part 2).
Reading the cytokine patterns
| Pattern | Interpretation |
|---|---|
| ↑ IL-2 / CCL4 + ↑ IFN-γ / CCL4 (T-cell driven) | Persistent intracellular infection — chronic Lyme dominant. |
| ↑↑ CCL5 / RANTES (vascular) | Long-COVID or post-vaccine endothelial inflammation. Klinghardt also links to retroviral activation. |
| ↑ CCR5 + ↑ sCD40L (platelet/vascular) | Long-COVID signature — vascular inflammation, platelet activation. Rationale for maraviroc + atorvastatin. |
| ↑ VEGF + ↑ IL-6 / TNF-α (innate, mold-pattern) | Mold / CIRS overlap — innate immune activation, capillary inflammation. |
| Mixed: ↑ IL-2/CCL4 + ↑↑ CCL5 | Dual driver — Lyme + post-COVID overlap. Both layers must be addressed. |
These patterns guide treatment selection — they are not stand-alone diagnostic. Always interpret in clinical context.
The Mold Connection
In our practice, this changes how we approach nearly every Lyme case.
turn out to also be mold cases.
Why mold matters
Mold weakens the immune system, suppresses immune surveillance, and disrupts detoxification pathways. That allows pathogens like Borrelia — which a healthy immune system would normally hold in check — to flourish.
If we don't address mold first or alongside Lyme, the patient often does not get better. Common sources include water-damaged buildings, leaky basements, contaminated HVAC systems, and post-flood homes.
The Post-COVID Resurgence
We've seen an explosion of stealth infections re-emerge since 2020.
| Era | Phase | What happened |
|---|---|---|
| Pre-2020 | Stable terrain | Patients with latent Lyme, EBV, or Bartonella often held it in check with a healthy immune system. |
| 2020–21 | Immune disruption | COVID infection — and immune-modulating effects of the vaccines for some patients — produced widespread immune dysregulation. |
| 2022–now | Stealth infections re-emerge | Latent Lyme, Bartonella, Babesia, EBV, and mycotoxin illness flaring in patients who were previously asymptomatic. |
COVID corrupted the hard drive — and Lyme came back online.
Do We All Have Lyme?
A provocative question — with a nuanced answer.
Many of us carry a low-grade Lyme burden. The difference is whose immune system holds it in check. What tips the balance toward symptomatic disease?
- Chronic emotional trauma or major life stress
- Mold exposure or water-damaged buildings
- Post-COVID or post-vaccine immune dysregulation
- Aging — Th2 dominance as immunity shifts
Retroviral Stress
Dr. Klinghardt's contribution to understanding stubborn chronic illness.
The hidden layer
Retroviruses are difficult to detect — they don't show up on standard testing. We detect them indirectly via markers like RANTES (CCL5). When retroviral stress is treated, the Lyme burden often drops dramatically — even without aggressive antimicrobials.
Tools we may use for retroviral support
- Sulforaphane / broccoli sprout extract
- Cistus incanus tea
- Retro-V powder (Ki Science)
- Selenium, lithium orotate
- Field Control Therapy (FCT) for energetic clearing
Why Antibiotics Often Fail Chronic Lyme
Not because Lyme isn't there — but because antibiotics alone can't reach all of it.
- They don't kill all forms. Antibiotics target actively replicating spirochetes — but miss cyst forms, L-forms, and dormant biofilm-protected bacteria.
- Biofilms block penetration. Biofilms can be 100+ times harder for antibiotics to penetrate than the bacteria themselves.
- Mold isn't addressed. If mold is present and untreated, the immune system can't recover — Lyme returns when antibiotics stop.
- They don't touch retroviruses. Antibiotics have no effect on the retroviral stress that drives much of chronic disease.
- They don't touch parasites. Parasitic and viral burdens that often present alongside Lyme go completely missed.
- Bartonella & Babesia get missed. Often left untreated — and often harder to clear than the Borrelia itself.
Kryptopyrroluria (KPU): How Lyme Hijacks Your Nutrient Stores
A cycle most clinicians have never been taught to look for.
- Stage 1 — Lyme drives KPU. Pyrrole molecules are produced and bind to zinc and B6, dragging them out of the body via urine.
- Stage 2 — The patient becomes depleted. Over time, B6 and zinc deficiency develops — both critical for nervous system and immune function.
- Stage 3 — Symptoms snowball. Anxiety, insomnia, pain, weakened immunity, and an even more hospitable terrain for the pathogen to persist.
We test for KPU early in evaluation — replenishing B6 and zinc is foundational to recovery.
Can We Ever Fully Eradicate Lyme?
An honest answer to the question every patient asks.
Probably not. But here's what we can do:
- Reduce pathogen burden to manageable levels.
- Strengthen the terrain so the immune system holds it in check.
- Build sustainable habits that keep Lyme dormant for life.
You're Not Crazy
Four takeaways if you've been suffering — what we hope you carry from Part 1.
Coming up in Part 2
Healing from Chronic Lyme — A Terrain-Based Roadmap
- Bioenergetic diagnostic tools (ART, FCT, CBT)
- Stabilizing the terrain & opening drainage
- Treating mold and environmental toxins
- Disrupting biofilms safely
- Targeting infections at the right time
- Maraviroc + atorvastatin for inflammation
- TruDOSE PRP — the immune system reset
- Putting it all together: our 8-step protocol
Plus a real patient case: from disability to vibrant life.
Begin Your Recovery Journey
If you’ve been told it’s “all in your head” or that your labs are “normal” but you still feel profoundly unwell — we believe you. And we can help.
Schedule a Free ConsultSources & Further Reading
Lyme epidemiology & clinical recognition
- CDC Lyme Disease Surveillance and Available Data — cdc.gov/lyme
- Horowitz, R. Why Can't I Get Better? Solving the Mystery of Lyme & Chronic Disease (2013)
- Under Our Skin (documentary, 2008) — patient stories of dismissal and chronic Lyme
Bioenergetic & integrative methods
- Klinghardt, D. — Autonomic Response Testing & 5 Levels of Healing — klinghardtinstitute.com
- Schaller, J. — Bartonella and the New Lyme Disease research
Long COVID, immune dysregulation, cytokine testing
- Patterson, B. et al. (2021–22) — Persistence of SARS-CoV-2 S1 in CD16+ monocytes; Long COVID and ME/CFS shared inflammatory biomarkers
- Radiance Diagnostics Long Hauler Index — theradiancediagnostics.com
Lyme & neurodegenerative disease
- MacDonald, A. — Spirochete biofilms in Alzheimer's brain tissue (multiple publications)
- Miklossy, J. — Chronic spirochetal infection and Alzheimer's disease (J. Neuroinflammation, 2011)
Advanced testing referenced
- T Lab — PCR + RNA FISH (tlabdx.com)
- Phelix Phage / RedLabs · InfectoLab Elispot · IGeneX ImmunoBlot + FISH · Vibrant Tickborne 2.0
Martin Van Lear, APRN, MSN, ABAAHP, FNP-C
Owner & Primary Provider · Tree of Light Health, LLC
2295 Parklake Dr NE, Ste. 110 · Atlanta, GA 30345
(404) 877-2385 · www.treeoflighthealth.com
© 2026 Tree of Light Health, LLC. This article is for educational purposes and does not constitute medical advice. Please consult your healthcare provider before making medical decisions. Watch for Part 2: Healing from Chronic Lyme — A Terrain-Based Roadmap, coming soon.